Teehan Brendan 4

What Happened Brendan Teehan, Chief Commercial Officer of Pacira BioSciences (PCRX), had 5,182 shares withheld on 2026-01-30 to satisfy tax withholding obligations related to restricted stock unit (RSU) vesting. The withheld shares were valued at $20.54 each, totaling approximately $106,438. This was a tax-withholding disposition (transaction code F), not an open-market sale.

Key Details

• Transaction date: 2026-01-30; Filing date: 2026-02-03 (Form 4 accession 0001628280-26-005154).
• Shares withheld/disposed: 5,182 at $20.54 per share; total value ≈ $106,438.
• Transaction code: F — shares withheld by issuer to cover tax withholding on RSU vesting.
• Shares owned after transaction: not specified in the filing.
• This was not a purchase or an open-market sale; it reflects a routine tax withholding upon vesting.

Context Share withholding to cover taxes is common when RSUs vest and generally does not indicate management buying or selling stock for investment reasons. For retail investors, note this reduces the insider's outstanding share count but is not typically interpreted as a directional signal about the insider's view of the company.